PTJ
AVNR

Paul Tudor Jones’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Paul Tudor Jones’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,895
Closed -$388K – 1786
2014
Q4 		$388K Sell
22,895
-104,575
-82% -$1.47M 0.01% 890
2014
Q3 		$1.52M Buy
+127,470
New +$870K 0.05% 173
2013
Q4 		– Sell
-42,100
Closed -$178K – 1445
2013
Q3 		$178K Buy
+42,100
New +$199K 0.01% 748

Paul Tudor Jones's AVNR Position: Q1 2015 in Review

Paul Tudor Jones sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 22,895 shares — an estimated $388K sold.

Paul Tudor Jones first reported a position in AVNR in Q3 2013 and held it in 3 quarters. The position peaked at $1.52M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Paul Tudor Jones reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Paul Tudor Jones sold 22,895 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $388K.
  • Paul Tudor Jones first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 3 quarters.
  • Paul Tudor Jones's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.52M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Tudor Investment Corp's 13F filing for Q1 2015, filed 15 May 2015.